Resistance to quinolones in pathogens causing urinary tract infections

Journal of Communicable Diseases

Volumn 29, Issue 3, 1997, Pages 263-267

  Kapoor, Hema ^b   Aggarwal, Pushpa ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM; DRUG EFFECT; ESCHERICHIA COLI; HUMAN; KLEBSIELLA; MICROBIOLOGY; PSEUDOMONAS; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; BACTERIA; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; FLUOROQUINOLONES; HUMANS; KLEBSIELLA; PSEUDOMONAS; URINARY TRACT INFECTIONS;

EID: 0031217478     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Aguiar JM, et al. The emergence of highly fluroquinolones resistant Escherichia coli in community acquired urinary tract infections. J Antimicrob Chemotherap, 1992 : 29 : 349-350
2. Muder RR, et al. Association with prior fluoroquinolone therapy Of widespread ciprofloxacin resistance among gram negative isolates in a veteran affairs medical centre. Antimicrob Agents Chemotherap, 1991; 35 : 256-258.
3. Perez-Trallero E, et al. Ten years survey of quinolone resistance in Escherichia coli causing UTI. Eur J Clin Microbial infect Dis. 1993; 12 : 349-351.
4. Stokes EJ and Ridgway GL. In Clinical bacteriology (5th ED), Edward Arnold, 1980, p. 205-209.
5. Manual In Susceptibility tests : Agar and Macrobroth dilution procedures American Society of Microbiologists. Eds Lennett et al, Chapter 42, 1980.
6. Goodman and Gillman. The Pharmacological Basis of Therapeutics. Vol 2, 8th Ed, McGraw Hill International Edition, p. 1058 1992.
7. Frieden T and Mangi RJ. Inappropriate use of oral ciproflocain. J Amer Med Assoc 1990 264 : 1438-1440.
8. Cheek WA. Physicians must rethink use of antibiotics to curb rise in drug resistant microbes. ACP Observer 1993; 13 : 15-19.
9. Llordes M, et al. Emergence of ciprofloxacin resistance in Esch coli. (Abstract No 1041 of 6th European Congress on Clinical Microbiology and Infectious Diseases, Sevilla, Spain 1993.
10. Hooper DC. Mechanism of action and resistance to ciprofloxacin. Amer J Med 82 : Suppl 1987; 82 : 4A 12-20.
11. Hooper DC. Mechanism of action and resistance to ciprofloxacin. Amer J Med 82 : Suppl 1987; 82 : 4A 12-20.
12. Heisig P and Tschomy R. Characterization of fluoroquinolone resistant mutants of Esch. coli selected in vitro. Antimicrob Agents Chemotherap 1994; 38 : 1284-1291.
13. Zhanel GG, et al. Development of multiple antibiotic resistance (Mar) mutants of Ps. aeruginosa after serial exposure to fluoroquinolones. Antimicrob Agents and Chemotherap, 1995 489-495.
14. Piddock LJU, et al. A pleiotropic post therapy enoxacin resistant mutants of Ps aeruginosa. Antimicrob Agents Chemotherap, 1992; 36 : 1057-1061.